F. Boyle

441 total citations
7 papers, 52 citations indexed

About

F. Boyle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, F. Boyle has authored 7 papers receiving a total of 52 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Genetics. Recurrent topics in F. Boyle's work include Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). F. Boyle is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). F. Boyle collaborates with scholars based in Australia, United Kingdom and United States. F. Boyle's co-authors include Joanne Shaw, Annie Young, Julie Winstanley, Corina van den Hurk, Young‐Hyuck Im, Priya Rastogi, SM Tolaney, Ashwin Shahir, J. O’Shaughnessy and Sarah C. Nabinger and has published in prestigious journals such as Annals of Oncology, Supportive Care in Cancer and The Breast.

In The Last Decade

F. Boyle

7 papers receiving 51 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Boyle Australia 4 25 18 13 10 7 7 52
Wendy Yared Belgium 4 14 0.6× 20 1.1× 3 0.2× 16 1.6× 4 0.6× 8 48
Sanjeeva Gunasekera Canada 5 21 0.8× 30 1.7× 10 0.8× 12 1.2× 1 0.1× 17 61
Gilliosa Spurrier Switzerland 2 16 0.6× 22 1.2× 3 0.2× 11 1.1× 2 0.3× 3 44
Gayle C. Blouin United States 4 11 0.4× 59 3.3× 18 1.4× 3 0.3× 2 0.3× 9 104
Christelle Levy France 4 8 0.3× 42 2.3× 13 1.0× 3 0.3× 4 0.6× 6 56
Marc Van den Bulcke Belgium 4 12 0.5× 10 0.6× 11 0.8× 7 0.7× 13 50
Joanna Lee Neumann United States 4 10 0.4× 11 0.6× 12 0.9× 5 0.5× 2 0.3× 7 46
Alexa Gillman United Kingdom 4 15 0.6× 15 0.8× 10 0.8× 12 1.2× 9 90
S.B. Vliek Netherlands 4 12 0.5× 15 0.8× 4 0.3× 15 1.5× 7 59
Nicole Scobie France 7 7 0.3× 15 0.8× 7 0.5× 7 0.7× 10 69

Countries citing papers authored by F. Boyle

Since Specialization
Citations

This map shows the geographic impact of F. Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Boyle more than expected).

Fields of papers citing papers by F. Boyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Boyle. The network helps show where F. Boyle may publish in the future.

Co-authorship network of co-authors of F. Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of F. Boyle. A scholar is included among the top collaborators of F. Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Boyle. F. Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Toi, Masakazu, F. Boyle, Young‐Hyuck Im, et al.. (2022). 59MO Adjuvant abemaciclib combined with endocrine therapy (ET): Efficacy results in monarchE cohort 1. Annals of Oncology. 33. S149–S149. 3 indexed citations
2.
3.
Johnston, Stephen, Nadia Harbeck, Roberto Hegg, et al.. (2020). LBA5_PR Abemaciclib in high risk early breast cancer. Annals of Oncology. 31. S1143–S1144. 2 indexed citations
4.
Mueller, Volkmar, Erika Hamilton, Amelia Zelnak, et al.. (2020). 275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM). Annals of Oncology. 31. S349–S350. 4 indexed citations
5.
Johnston, S., Nadia Harbeck, Roberto Hegg, et al.. (2020). 2MO Abemaciclib in high risk early breast cancer. Annals of Oncology. 31. S1242–S1243. 2 indexed citations
6.
Hurk, Corina van den, Julie Winstanley, Annie Young, & F. Boyle. (2015). Measurement of chemotherapy-induced alopecia—time to change. Supportive Care in Cancer. 23(5). 1197–1199. 11 indexed citations
7.
Shaw, Joanne, et al.. (2010). Communication about high-cost drugs in oncology—the patient view. Annals of Oncology. 21(9). 1910–1914. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Yared Breakdown of academic impact, for papers by Sanjeeva Gunasekera Breakdown of academic impact, for papers by Gilliosa Spurrier Breakdown of academic impact, for papers by Gayle C. Blouin Breakdown of academic impact, for papers by Christelle Levy Breakdown of academic impact, for papers by Marc Van den Bulcke Breakdown of academic impact, for papers by Joanna Lee Neumann Breakdown of academic impact, for papers by Alexa Gillman Breakdown of academic impact, for papers by S.B. Vliek Breakdown of academic impact, for papers by Nicole Scobie
Rankless by CCL
2026